Los Angeles Capital Management & Equity Research Inc. lessened its position in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 70.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,740 shares of the medical instruments supplier’s stock after selling 4,230 shares during the quarter. Los Angeles Capital Management & Equity Research Inc.’s holdings in ICU Medical were worth $323,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of ICU Medical by 10.3% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 707 shares of the medical instruments supplier’s stock worth $122,000 after purchasing an additional 66 shares during the period. Riverhead Capital Management LLC boosted its holdings in shares of ICU Medical by 99.8% in the 2nd quarter. Riverhead Capital Management LLC now owns 999 shares of the medical instruments supplier’s stock worth $172,000 after purchasing an additional 499 shares during the period. Victory Capital Management Inc. boosted its holdings in shares of ICU Medical by 17.6% in the 2nd quarter. Victory Capital Management Inc. now owns 1,050 shares of the medical instruments supplier’s stock worth $181,000 after purchasing an additional 157 shares during the period. Teacher Retirement System of Texas purchased a new position in shares of ICU Medical in the 2nd quarter worth approximately $214,000. Finally, Ameritas Investment Partners Inc. boosted its holdings in shares of ICU Medical by 4.0% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 1,321 shares of the medical instruments supplier’s stock worth $228,000 after purchasing an additional 51 shares during the period. Institutional investors and hedge funds own 78.14% of the company’s stock.
ICU Medical, Inc. (ICUI) opened at $211.15 on Monday. ICU Medical, Inc. has a 1-year low of $127.00 and a 1-year high of $218.45. The company has a current ratio of 4.65, a quick ratio of 3.01 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $4,250.66, a price-to-earnings ratio of 82.80, a P/E/G ratio of 3.39 and a beta of 0.36.
ICUI has been the subject of a number of recent research reports. Gabelli reiterated a “buy” rating on shares of ICU Medical in a report on Friday, August 11th. BidaskClub cut ICU Medical from a “hold” rating to a “sell” rating in a report on Thursday, August 24th. Zacks Investment Research cut ICU Medical from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 15th. Finally, KeyCorp started coverage on ICU Medical in a report on Tuesday, October 17th. They set a “sector weight” rating for the company. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company’s stock. ICU Medical presently has a consensus rating of “Hold” and a consensus price target of $232.00.
In other ICU Medical news, VP Virginia Ruth Sanzone sold 1,784 shares of ICU Medical stock in a transaction on Thursday, September 7th. The stock was sold at an average price of $174.47, for a total transaction of $311,254.48. Following the completion of the sale, the vice president now directly owns 102 shares of the company’s stock, valued at approximately $17,795.94. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Robert S. Swinney sold 1,000 shares of ICU Medical stock in a transaction on Tuesday, November 28th. The shares were sold at an average price of $215.10, for a total value of $215,100.00. Following the sale, the director now directly owns 13,330 shares of the company’s stock, valued at $2,867,283. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 121,447 shares of company stock valued at $23,198,692. 13.60% of the stock is owned by company insiders.
ICU Medical Profile
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI).
What are top analysts saying about ICU Medical Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for ICU Medical Inc. and related companies.